首页/数据集/Additional file 3 of Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma

Additional file 3 of Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma

NIAID Data Ecosystem2026-05-02 收录

胆管癌分子标志物

数据链接：

https://figshare.com/articles/dataset/Additional_file_3_of_Unveiling_the_role_of_HP1_-HDAC1-STAT1_axis_as_a_therapeutic_target_for_HP1_-positive_intrahepatic_cholangiocarcinoma/25929117 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 3

应用场景：

创建时间：

2024-05-30

胆管癌分子标志物

PD-L1

Association of Jumonji domain-containing 6 (JMJD6) with outcomes of various cancers has been shown, however the impact on intrahepatic cholangiocarcinoma (ICC) has never been reported yet. The aim of

NIAID Data Ecosystem100

Value of Glycogen Synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells

胆管癌分子标志物

肿瘤代谢重编程机制

Intrahepatic cholangiocarcinoma is the second most common primary liver tumor with increasing incidence worldwide. Metabolic reprogramming caused by metabolic related gene disorders is a prominent hal

Taylor & Francis Group2024-02-14 更新20

Gene expression signatures for Intrahepatic cholangiocarcinoma

胆管癌分子标志物

circRNA表达谱

CircRNA microarray was used to screen significantly up-regulated circRNAs in paired ICC and non-tumor tissues 7 paired ICC and non-tumor tissues was used to screen significantly CircRNAs

DataMed10

microRNA profile of human intrahepatic cholangiocarcinoma: intrahepatic cholangiocarcinoma vs. normal intrahepatic bile duct tissue

胆管癌分子标志物

miRNA预后预测

MicroRNA expression profiles were sucessfully contructed in 63 patients with ICC and 9 normal intrahepatic bile ducts using a custom microarray containing probes for 1094 miRNAs and an outcome predict

NIAID Data Ecosystem40

Table_1_Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.docx

癌症免疫治疗预后预测

胆管癌分子标志物

BackgroundImmune checkpoint inhibitor (ICI)-combined chemotherapy in advanced intrahepatic cholangiocarcinoma has been proved to have more efficacy in a series of clinical trials. However, whether the

NIAID Data Ecosystem20

Additional file 3 of Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma

资源简介：

相关数据集